| 生物活性 | |||
|---|---|---|---|
| 描述 | The interaction of co-stimulatory molecules on T cells with B7 molecules on antigen presenting cells plays an important role in the activation of naive T cells. Agents that disrupt these interactions should have applications in treatment of transplant rejection as well as autoimmune diseases. B7/CD28 interaction inhibitor 1 is a potent small molecule inhibitor of the B7.1-CD28 interaction with an IC50 of 50 nM[2]. | ||
| 作用机制 | B7/CD28 interaction inhibitor 1 binds to the V-like domain of human B7.1[2]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.34mL 0.47mL 0.23mL |
11.70mL 2.34mL 1.17mL |
23.40mL 4.68mL 2.34mL |
| 参考文献 |
|---|